OPW
BIIB icon

Oxler Private Wealth’s Biogen BIIB Stock Holding History

Oxler Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,380
Closed -$956K – 120
2021
Q3 		$956K Hold
3,380
– – 0.42% 65
2021
Q2 		$1.17M Hold
3,380
– – 0.51% 56
2021
Q1 		$945K Hold
3,380
– – 0.48% 57
2020
Q4 		$827K Buy
+3,380
New +$872K 0.47% 46

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Oxler Private Wealth's BIIB Position: Q4 2021 in Review

Oxler Private Wealth sold out of Biogen (BIIB) in Q4 2021, closing a stake of 3,380 shares — an estimated $956K sold.

Oxler Private Wealth first reported a position in BIIB in Q4 2020 and held it in 4 quarters. The position peaked at $1.17M in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Oxler Private Wealth reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Oxler Private Wealth sold 3,380 Biogen shares in Q4 2021, an estimated $956K.
  • Oxler Private Wealth first reported a position in Biogen in Q4 2020 and held it in 4 quarters.
  • Oxler Private Wealth's Biogen position peaked at $1.17M in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Oxler Private Wealth's 13F filing for Q4 2021, filed 27 Jan 2022.